Cancer clinical trial participants' assessment of risk and benefit

, , , , &
AJOB Empirical Bioethics 7 (1):8-16 (2016)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/23294515.2015.1034381

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 103,449

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Connie M. Ulrich & Christine Grady, Moral Distress in the Health Professions.Mohammad J. Thalgi - 2020 - Ethical Theory and Moral Practice 23 (3-4):681-683.
Cancer Clinical Trial Patient-Participants’ Perceptions about Provider Communication and Dropout Intentions.Qiuping Zhou, Sarah J. Ratcliffe, Christine Grady, Tianhao Wang, Jun J. Mao & Connie M. Ulrich - 2019 - AJOB Empirical Bioethics 10 (3):190-200.
Utilizing Focus Groups with Potential Participants and Their Parents: An Approach to Inform Study Design in a Large Clinical Trial.Sandeep Kadimpati, Jennifer B. McCormick, Yichen Chiu, Ashley B. Parker, Aliya Z. Iftikhar, Randall P. Flick & David O. Warner - 2014 - AJOB Empirical Bioethics 5 (3):31-38.
Preventive Misconception and Risk Behaviors in a Multinational HIV Prevention Trial.Jeremy Sugarman, Li Lin, Jared M. Baeten, Thesla Palanee-Phillips, Elizabeth R. Brown, Flavia Matovu Kiweewa, Nyaradzo M. Mgodi, Gonasagrie Nair, Samantha Siva, Damon M. Seils & Kevin P. Weinfurt - 2019 - AJOB Empirical Bioethics 10 (2):79-87.
Informed Consent among Clinical Trial Participants with Different Cancer Diagnoses.Connie M. Ulrich, Sarah J. Ratcliffe, Camille J. Hochheimer, Qiuping Zhou, Liming Huang, Thomas Gordon, Kathleen Knafl, Therese Richmond, Marilyn M. Schapira, Victoria Miller, Jun J. Mao, Mary Naylor & Christine Grady - 2024 - AJOB Empirical Bioethics 15 (3):165-177.
Ethical Issues in International Biomedical Research: A Casebook – Edited by James V. Lavery, Christine Grady, Elizabeth R. Wahl and Ezekiel J. Emanuel. [REVIEW]John R. Williams - 2008 - Developing World Bioethics 8 (2):164-165.
The assessment of the risk - benefit ratio of phase II cancer clinical trials by Institutional Review Board members.A. W. Musschenga - unknown
Risky first-in-human clinical trials on medically fragile persons: owning the moral cost.Christopher Bobier - 2024 - Theoretical Medicine and Bioethics 45 (6):447-459.
Clinicians or Researchers, Patients or Participants: Exploring Human Subject Protection When Clinical Research Is Conducted in Non-academic Settings.Ann Freeman Cook & Helena Hoas - 2014 - AJOB Empirical Bioethics 5 (1):3-11.
“I Want to Do It, But I Want to Make Sure That I Do It Right.” Views of Patients with Parkinson’s Disease Regarding Early Stem Cell Clinical Trial Participation.Inmaculada de Melo-Martín, Michael Holtzman & Katrina S. Hacker - 2020 - AJOB Empirical Bioethics 11 (3):160-171.

Analytics

Added to PP
2015-05-03

Downloads
70 (#311,921)

6 months
13 (#197,488)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Tissue vs Liquid Biopsies for Cancer Detection: Ethical Issues.Chiara Mannelli - 2019 - Journal of Bioethical Inquiry 16 (4):551-557.

Add more citations

References found in this work

Principles of biomedical ethics.Tom L. Beauchamp - 1989 - New York: Oxford University Press. Edited by James F. Childress.
Ethics and regulation of clinical research.Robert J. Levine - 1986 - Baltimore: Urban & Schwarzenberg.
Forced to be free? Increasing patient autonomy by constraining it.Neil Levy - 2014 - Journal of Medical Ethics 40 (5):293-300.

View all 18 references / Add more references